Company Description
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States.
The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions.
The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021.
Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Country | United States |
Founded | 1993 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 1,200 |
CEO | Gregory J. Crawford |
Contact Details
Address: 1019 Town Drive Wilder, Kentucky 41076 United States | |
Phone | 859-878-2220 |
Website | quipthomemedical.com |
Stock Details
Ticker Symbol | QIPT |
Exchange | NASDAQ |
Fiscal Year | October - September |
Reporting Currency | USD |
CIK Code | 0001540013 |
CUSIP Number | 74880P104 |
ISIN Number | CA74880P1045 |
SIC Code | 8090 |
Key Executives
Name | Position |
---|---|
Gregory J. Crawford | Chairman, President and Chief Executive Officer |
Hardik Mehta | Chief Financial Officer |
David Bachelder | Executive Vice President of Operations |
William Todd Zehnder | Chief Strategy Officer and Investor Relations |
Cole Stevens | Vice President of Corporate Development and VP of Investor Relations |
Mark Miles | Vice President of Information Technology |
Thomas W. Roehrig | Executive Vice President of Finance |
Robert Grossman LLB | Corporate Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 12, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
Apr 12, 2024 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
Apr 2, 2024 | 40-F/A | Filing |
Mar 28, 2024 | 6-K | Report of foreign issuer |
Mar 26, 2024 | F-10/A | Filing |
Mar 13, 2024 | 6-K | Report of foreign issuer |
Feb 28, 2024 | 6-K | Report of foreign issuer |
Feb 15, 2024 | 6-K | Report of foreign issuer |
Feb 14, 2024 | 6-K | Report of foreign issuer |
Feb 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |